ArticleHemaSphere2022

Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival.

Michael Winkelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.